# Avalon Ventures

> Avalon Ventures is a VC fund in La Jolla backing Software and Health Care. See 157 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: La Jolla, United States
- Total investments: 157
- Last investment: Apr 2024
- Lead investor: 31%
- Fund size: $116M
- Last fund: Sep 2016
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/avalon-ventures
- X (Twitter): http://twitter.com/AvalonVentures
- Website: http://www.avalon-ventures.com
- Facebook: https://www.facebook.com/pages/Avalon-Ventures/111377768905156

Avalon Ventures is an early stage venture capital fund focused on information technology and life sciences.

## Contacts

5 contacts available for Avalon Ventures. Shizune tracks 5 team members at Avalon Ventures. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/avalon-ventures?utm_source=investor_profile

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2.2M–$20M |
| Series B | $5M–$34M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Software | 22 | 14% |
| Health Care | 20 | 13% |
| Biotechnology | 18 | 11% |
| Enterprise Software | 12 | 8% |
| Mobile | 11 | 7% |

128 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 49 | 31% |
| Series B | 34 | 22% |
| Funding Round | 19 | 12% |
| Seed | 17 | 11% |
| Series C | 10 | 6% |

11 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 78 | 50% |
| United Kingdom | 2 | 1% |
| Denmark | 1 | 1% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Court Turner | Venture Partner | 0 | https://shizune.co/investors/profile/court-turner |
| Kevin Kinsella | Founder and Managing Director | 7 | https://shizune.co/investors/profile/kevin-kinsella |
| Steve Tomlin | Managing Member | 2 | https://shizune.co/investors/profile/stephen-tomlin |
| Brady Bohrmann | Managing Member | 26 | https://shizune.co/investors/profile/brady-bohrmann |
| Richard Levandov | Partner | 47 | https://shizune.co/investors/profile/richard-levandov |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Enlaza Therapeutics | Enlaza Therapeutics is a biotechnology research company. It was founded in 2020 and is headquartered in La Jolla, California. | $100M | Series A | Apr 30, 2024 |  |
| Vocera Communications | Vocera provides mobile communication solutions addressing critical communication challenges facing hospitals today. They help their customers improve patient safety and satisfaction, and increase hospital efficiency and productivity through their Voice Communication solution, Secure Messaging applications and Care Transition solutions. Exclusivelyendorsed by the American Hospital Association, the Vocera solutions are installed in more than 800 hospitals and healthcare facilities worldwide. The company is headquartered in San Jose, Calif., with offices in Tennessee, Canada and the United Kingdom. | $8M | Post-IPO Equity | May 08, 2023 |  |
| Jnana Therapeutics | Jnana Therapeutics is a biotechnology company focused on discovering and developing medicines that improve patient lives. Utilizing its RAPID platform, the firm accelerates the identification of therapeutic targets and the creation of small molecule therapies for various diseases. Jnana aims to enhance drug discovery efficiency through advancedchemoproteomics techniques, addressing unmet medical needs. | $107M | Series C | Nov 15, 2022 |  |
| Enlaza Therapeutics | Enlaza Therapeutics is a biotechnology research company. It was founded in 2020 and is headquartered in La Jolla, California. | $61M | Seed | Oct 12, 2022 |  |
| Joy | Joy is a wedding company that gives couples a smarter way to plan their big day. Using Joy, couples can create a beautifully-designed wedding website and mobile app, build their All-in-One Registry, manage guest lists and RSVPs, send online or printed Save the Dates, invitations and eCards, provide travel and accommodations options for guests, hostvirtual wedding events, create a shared virtual wedding album and virtual guest book, and more. Wedding guests can purchase registry gifts, book travel plans and accommodations, get directions to wedding events via a Google Maps integration, order a ride to wedding events via ride-sharing integrations, add wedding events to their calendar with a click, and more.Based in San Francisco, Joy launched in 2016 through Y Combinator. Visit withjoy.com and follow @withjoy to see why couples around the world are planning their weddings with Joy. | $20M | Series A | Sep 01, 2021 |  |
| Jnana Therapeutics | Jnana Therapeutics is a biotechnology company focused on discovering and developing medicines that improve patient lives. Utilizing its RAPID platform, the firm accelerates the identification of therapeutic targets and the creation of small molecule therapies for various diseases. Jnana aims to enhance drug discovery efficiency through advancedchemoproteomics techniques, addressing unmet medical needs. | $50M | Series B | Aug 18, 2021 |  |
| Primer | Primer is an internet company that helps companies understand massive stores of text data using AI. It uses machine learning techniques to help parse and collate a large number of documents across several languages in order to facilitate further investigation. It was founded in 2015 and headquartered in San Francisco, California. | $110M | Series C | Jun 22, 2021 |  |
| Janux Therapeutics | Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response. | $125M | Series B | Apr 20, 2021 |  |
| Fortis Therapeutics | Fortis Therapeutics is immuno-oncology biotech focused on developing new antibody-drug conjugate therapies against CD46 for the treatment of late-stage multiple myeloma and late-stage prostate cancer and other indications. | $40M | Series A | Mar 29, 2021 |  |
| Janux Therapeutics | Janux Therapeutics develops immunotherapies that generate immune responses to prevent tumors and not affecting a patient’s healthy tissue. Janux technology targets all three stages of the anti-tumor immune response. | $56M | Series A | Mar 03, 2021 |  |

10 of 157 investments shown.

## Co-investors
- [Austin Ventures](https://shizune.co/investors/profile/austin-ventures) — VC Fund, 8 deals together
- [Foundry Group](https://shizune.co/investors/profile/foundryvc) — VC Fund, 8 deals together
- [Sigma Partners](https://shizune.co/investors/profile/sigma-partners) — VC Fund, 8 deals together
- [Union Square Ventures](https://shizune.co/investors/profile/union-square-ventures) — VC Fund, 7 deals together
- [Versant Ventures](https://shizune.co/investors/profile/versant-ventures) — VC Fund, 7 deals together
- [Bregua](https://shizune.co/investors/profile/bregua-corporation) — VC Fund, 6 deals together

## Similar investors

### Similar industry
- [ff Venture Capital](https://shizune.co/investors/profile/ff-venture-capital) — VC Fund
- [Play Ventures](https://shizune.co/investors/profile/play-ventures) — VC Fund
- [SilverCircle](https://shizune.co/investors/profile/silvercircle) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Retail VC Funds in United States](https://shizune.co/investors/retail-vc-funds-united-states)
- [Hospitality VC Funds in United States](https://shizune.co/investors/hospitality-vc-funds-united-states)
- [Restaurants Investors in United States](https://shizune.co/investors/restaurants-investors-united-states)
- [Restaurants VC Funds in United States](https://shizune.co/investors/restaurants-vc-funds-united-states)
- [Social Network Investors in United States](https://shizune.co/investors/social-network-investors-united-states)
- [Social Network VC Funds in United States](https://shizune.co/investors/social-network-vc-funds-united-states)

## FAQ

### What does Avalon Ventures invest in?

Avalon Ventures invests primarily in Software, Health Care and Biotechnology startups, most often at Series A and Series B stage. Most of the 157 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Avalon Ventures's check size?

Avalon Ventures typically joins rounds of $2.2M–$20M at Series A and $5M–$34M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Avalon Ventures participates in.

### How do I contact Avalon Ventures?

Public channels for Avalon Ventures include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Avalon Ventures?

The team at Avalon Ventures includes Court Turner (Venture Partner), Kevin Kinsella (Founder and Managing Director) and Steve Tomlin (Managing Member). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co